212 related articles for article (PubMed ID: 24524764)
1. Peptides for diagnosis and treatment of colorectal cancer.
Shapira S; Fokra A; Arber N; Kraus S
Curr Med Chem; 2014; 21(21):2410-6. PubMed ID: 24524764
[TBL] [Abstract][Full Text] [Related]
2. Targeted immunotherapy for colorectal cancer: monoclonal antibodies and immunotoxins.
Shapira S; Lisiansky V; Arber N; Kraus S
Expert Opin Investig Drugs; 2010 Apr; 19 Suppl 1():S67-77. PubMed ID: 20374033
[TBL] [Abstract][Full Text] [Related]
3. The use of therapeutic peptides to target and to kill cancer cells.
Boohaker RJ; Lee MW; Vishnubhotla P; Perez JM; Khaled AR
Curr Med Chem; 2012; 19(22):3794-804. PubMed ID: 22725698
[TBL] [Abstract][Full Text] [Related]
4. A Concise Review on the Role of Natural and Synthetically Derived Peptides in Colorectal Cancer.
Das A; Deka D; Banerjee A; Radhakrishnan AK; Zhang H; Sun XF; Pathak S
Curr Top Med Chem; 2022; 22(31):2571-2588. PubMed ID: 35578849
[TBL] [Abstract][Full Text] [Related]
5. The feasibility of Cep55/c10orf3 derived peptide vaccine therapy for colorectal carcinoma.
Inoda S; Morita R; Hirohashi Y; Torigoe T; Asanuma H; Nakazawa E; Nakatsugawa M; Tamura Y; Kamiguchi K; Tsuruma T; Terui T; Ishitani K; Hashino S; Wang Q; Greene MI; Hasegawa T; Hirata K; Asaka M; Sato N
Exp Mol Pathol; 2011 Feb; 90(1):55-60. PubMed ID: 20950610
[TBL] [Abstract][Full Text] [Related]
6. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
7. Recent advances and applications of peptide-agent conjugates for targeting tumor cells.
Alamdari-Palangi V; Jaberi KR; Shahverdi M; Naeimzadeh Y; Tajbakhsh A; Khajeh S; Razban V; Fallahi J
J Cancer Res Clin Oncol; 2023 Nov; 149(16):15249-15273. PubMed ID: 37581648
[TBL] [Abstract][Full Text] [Related]
8. Receptor-mediated tumor targeting based on peptide hormones.
Mezo G; Manea M
Expert Opin Drug Deliv; 2010 Jan; 7(1):79-96. PubMed ID: 19947889
[TBL] [Abstract][Full Text] [Related]
9. A novel peptide specifically targeting the vasculature of orthotopic colorectal cancer for imaging detection and drug delivery.
Li ZJ; Wu WK; Ng SS; Yu L; Li HT; Wong CC; Wu YC; Zhang L; Ren SX; Sun XG; Chan KM; Cho CH
J Control Release; 2010 Dec; 148(3):292-302. PubMed ID: 20854857
[TBL] [Abstract][Full Text] [Related]
10. Update: improvement strategies for peptide receptor scintigraphy and radionuclide therapy.
de Visser M; Verwijnen SM; de Jong M
Cancer Biother Radiopharm; 2008 Apr; 23(2):137-57. PubMed ID: 18454684
[TBL] [Abstract][Full Text] [Related]
11. The potential role of immunotherapy to treat colorectal cancer.
Amin M; Lockhart AC
Expert Opin Investig Drugs; 2015 Mar; 24(3):329-44. PubMed ID: 25519074
[TBL] [Abstract][Full Text] [Related]
12. Exploring Different Strategies for Efficient Delivery of Colorectal Cancer Therapy.
Lin C; Ng HL; Pan W; Chen H; Zhang G; Bian Z; Lu A; Yang Z
Int J Mol Sci; 2015 Nov; 16(11):26936-52. PubMed ID: 26569228
[TBL] [Abstract][Full Text] [Related]
13. Insight to drug delivery aspects for colorectal cancer.
Gulbake A; Jain A; Jain A; Jain A; Jain SK
World J Gastroenterol; 2016 Jan; 22(2):582-99. PubMed ID: 26811609
[TBL] [Abstract][Full Text] [Related]
14. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
15. Colorectal cancer vaccines: Tumor-associated antigens
Wagner S; Mullins CS; Linnebacher M
World J Gastroenterol; 2018 Dec; 24(48):5418-5432. PubMed ID: 30622371
[TBL] [Abstract][Full Text] [Related]
16. Personalized Peptide-based Vaccination for Treatment of Colorectal Cancer: Rational and Progress.
Parizadeh SM; Jafarzadeh-Esfehani R; Ghandehari M; Rezaei-Kalat A; Parizadeh SMR; Javanbakht A; Hassanian SM; Ferns GA; Khazaei M; Avan A
Curr Drug Targets; 2019; 20(14):1486-1495. PubMed ID: 31237205
[TBL] [Abstract][Full Text] [Related]
17. Radiometallation of receptor-specific peptides for diagnosis and treatment of human cancer.
Giblin MF; Veerendra B; Smith CJ
In Vivo; 2005; 19(1):9-29. PubMed ID: 15796153
[TBL] [Abstract][Full Text] [Related]
18. Cancer immunotherapy: present status, future perspective, and a new paradigm of peptide immunotherapeutics.
Miller MJ; Foy KC; Kaumaya PT
Discov Med; 2013 Mar; 15(82):166-76. PubMed ID: 23545045
[TBL] [Abstract][Full Text] [Related]
19. Targeted therapy for colorectal cancer: mapping the way.
Mocellin S; Lise M; Nitti D
Trends Mol Med; 2005 Jul; 11(7):327-35. PubMed ID: 15950539
[TBL] [Abstract][Full Text] [Related]
20. Nanotechnology is an important strategy for combinational innovative chemo-immunotherapies against colorectal cancer.
Matos AI; Carreira B; Peres C; Moura LIF; Conniot J; Fourniols T; Scomparin A; Martínez-Barriocanal Á; Arango D; Conde JP; Préat V; Satchi-Fainaro R; Florindo HF
J Control Release; 2019 Aug; 307():108-138. PubMed ID: 31226355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
